Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Beer, TM; Pierce, WC; Lowe, BA; Henner, WD
   Phase II study of weekly docetaxel in symptomatic androgen-independent prostate cancer
   ANNALS OF ONCOLOGY
   
   T.M. Beer et al., "Phase II study of weekly docetaxel in symptomatic androgen-independent prostate cancer", ANN ONCOL, 12(9), 2001, pp. 1273-1279
2. Liu, DY; Liao, MX; Zuo, J; Henner, WD; Fang, FD
   The effect of chemical carcinogenesis on rat glutathione S-transferase P1 gene transcriptional regulation
   MOLECULAR BIOLOGY REPORTS
   
   D.Y. Liu et al., "The effect of chemical carcinogenesis on rat glutathione S-transferase P1 gene transcriptional regulation", MOL BIOL RP, 28(1), 2001, pp. 19-25
3. Henner, WD; Evans, AJ; Hough, KM; Harris, EL; Lowe, BA; Beer, TM
   Association of codon 72 polymorphism of p53 with lower prostate cancer risk
   PROSTATE
   
   W.D. Henner et al., "Association of codon 72 polymorphism of p53 with lower prostate cancer risk", PROSTATE, 49(4), 2001, pp. 263-266
4. Sanderson, BJS; Johnson, KJ; Henner, WD
   Induction of mutant lymphocytes in cyclophosphamide- and chlorambucil-treated patients
   MUTAGENESIS
   
   B.J.S. Sanderson et al., "Induction of mutant lymphocytes in cyclophosphamide- and chlorambucil-treated patients", MUTAGENESIS, 16(3), 2001, pp. 197-202
5. Beer, TM; Hough, KM; Garzotto, M; Lowe, BA; Henner, WD
   Weekly high-dose calcitriol and docetaxel in advanced prostate cancer
   SEMINARS IN ONCOLOGY
   
   T.M. Beer et al., "Weekly high-dose calcitriol and docetaxel in advanced prostate cancer", SEMIN ONCOL, 28(4), 2001, pp. 49-55
6. Beer, TM; Munar, M; Henner, WD
   A phase I trial of pulse calcitriol in patients with refractory malignancies - Pulse dosing permits substantial dose escalation
   CANCER
   
   T.M. Beer et al., "A phase I trial of pulse calcitriol in patients with refractory malignancies - Pulse dosing permits substantial dose escalation", CANCER, 91(12), 2001, pp. 2431-2439
7. McWilliams, JE; Evans, AJ; Beer, TM; Andersen, PE; Cohen, JI; Everts, EC; Henner, WD
   Genetic polymorphisms in head and neck cancer risk
   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
   
   J.E. McWilliams et al., "Genetic polymorphisms in head and neck cancer risk", HEAD NECK, 22(6), 2000, pp. 609-617
8. Walkhom, B; Fraunfelder, FT; Henner, WD
   Severe ocular irritation and corneal deposits associated with capecitabineuse
   NEW ENGLAND JOURNAL OF MEDICINE
   
   B. Walkhom et al., "Severe ocular irritation and corneal deposits associated with capecitabineuse", N ENG J MED, 343(10), 2000, pp. 740-741
9. KAUVAR LM; MORGAN AS; SANDERSON PE; HENNER WD
   GLUTATHIONE BASED APPROACHES TO IMPROVING CANCER-TREATMENT
   Chemico-biological interactions
   
   L.M. Kauvar et al., "GLUTATHIONE BASED APPROACHES TO IMPROVING CANCER-TREATMENT", Chemico-biological interactions, 112, 1998, pp. 225-238
10. MORGAN AS; SANDERSON PE; BORCH RF; TEW KD; NIITSU Y; TAKAYAMA T; VONHOFF DD; IZBICKA E; MANGOLD G; PAUL C; BROBERG U; MANNERVIK B; HENNER WD; KAUVAR LM
    TUMOR EFFICACY AND BONE MARROW-SPARING PROPERTIES OF TER286, A CYTOTOXIN ACTIVATED BY GLUTATHIONE-S-TRANSFERASE
    Cancer research
    
    A.S. Morgan et al., "TUMOR EFFICACY AND BONE MARROW-SPARING PROPERTIES OF TER286, A CYTOTOXIN ACTIVATED BY GLUTATHIONE-S-TRANSFERASE", Cancer research, 58(12), 1998, pp. 2568-2575
11. TRAN T; HENNER WD; MCWILLIAMS J; PRESS R
    IRON AND CANCER RISK - HFE (HEMOCHROMATOSIS) GENE MUTATION ANALYSIS IN CANCER-PATIENTS
    The American journal of pathology
    
    T. Tran et al., "IRON AND CANCER RISK - HFE (HEMOCHROMATOSIS) GENE MUTATION ANALYSIS IN CANCER-PATIENTS", The American journal of pathology, 153(5), 1998, pp. 12-12
12. IZUMI T; HENNER WD; MITRA S
    PROMOTER FUNCTION OF THE HUMAN AP-ENDONUCLEASE
    The FASEB journal
    
    T. Izumi et al., "PROMOTER FUNCTION OF THE HUMAN AP-ENDONUCLEASE", The FASEB journal, 10(6), 1996, pp. 42-42
13. DELOUGHERY TG; EVANS A; SADEGHI A; MCWILLIAMS J; HENNER WD; TAYLOR LM; PRESS RD
    COMMON MUTATION IN METHYLENETETRAHYDROFOLATE REDUCTASE - CORRELATION WITH HOMOCYSTEINE METABOLISM AND LATE-ONSET VASCULAR-DISEASE
    Circulation
    
    T.G. Deloughery et al., "COMMON MUTATION IN METHYLENETETRAHYDROFOLATE REDUCTASE - CORRELATION WITH HOMOCYSTEINE METABOLISM AND LATE-ONSET VASCULAR-DISEASE", Circulation, 94(12), 1996, pp. 3074-3078
14. DELOUGHERY TG; WISNER TW; EVANS AJ; MCWILLIAMS JC; HENNER WD; PRESS RD
    MOLECULAR-DETECTION AND GENE-FREQUENCY IN CONTROL POPULATIONS OF THE COMMON CYS282TYR MUTATION IMPLICATED IN HEREDITARY HEMOCHROMATOSIS
    Blood
    
    T.G. Deloughery et al., "MOLECULAR-DETECTION AND GENE-FREQUENCY IN CONTROL POPULATIONS OF THE COMMON CYS282TYR MUTATION IMPLICATED IN HEREDITARY HEMOCHROMATOSIS", Blood, 88(10), 1996, pp. 1948-1948
15. IZUMI T; HENNER WD; SANKAR MS
    NEGATIVE REGULATION OF THE MAJOR HUMAN AP-ENDONUCLEASE, A MULTIFUNCTIONAL PROTEIN
    Biochemistry
    
    T. Izumi et al., "NEGATIVE REGULATION OF THE MAJOR HUMAN AP-ENDONUCLEASE, A MULTIFUNCTIONAL PROTEIN", Biochemistry, 35(47), 1996, pp. 14679-14683
16. MCWILLIAMS JE; SANDERSON BJS; HARRIS EL; RICHERTBOE KE; HENNER WD
    GLUTATHIONE-S-TRANSFERASE M1 (GSTM1) DEFICIENCY AND LUNG-CANCER RISK
    Cancer epidemiology, biomarkers & prevention
    
    J.E. Mcwilliams et al., "GLUTATHIONE-S-TRANSFERASE M1 (GSTM1) DEFICIENCY AND LUNG-CANCER RISK", Cancer epidemiology, biomarkers & prevention, 4(6), 1995, pp. 589-594
17. IZUMI T; WARD JB; HENNER WD; AUE W; TATSUKA M; MITRA S
    GENE TARGETING OF THE AP-ENDONUCLEASE (APE) GENE IN A HUMAN LYMPHOBLASTOID CELL-LINE
    Journal of cellular biochemistry
    
    T. Izumi et al., "GENE TARGETING OF THE AP-ENDONUCLEASE (APE) GENE IN A HUMAN LYMPHOBLASTOID CELL-LINE", Journal of cellular biochemistry, 1995, pp. 279-279
18. WILLIAMS PC; HENNER WD; ROMANGOLDSTEIN S; DAHLBORG SA; BRUMMETT RE; TABLEMAN M; DANA BW; NEUWELT EA
    TOXICITY AND EFFICACY OF CARBOPLATIN AND ETOPOSIDE IN CONJUNCTION WITH DISRUPTION OF THE BLOOD-BRAIN TUMOR BARRIER IN THE TREATMENT OF INTRACRANIAL NEOPLASMS
    Neurosurgery
    
    P.C. Williams et al., "TOXICITY AND EFFICACY OF CARBOPLATIN AND ETOPOSIDE IN CONJUNCTION WITH DISRUPTION OF THE BLOOD-BRAIN TUMOR BARRIER IN THE TREATMENT OF INTRACRANIAL NEOPLASMS", Neurosurgery, 37(1), 1995, pp. 17-27
19. NEUWELT EA; DAHLBORG SA; HENNER WD; CROSSEN JR; TABLEMAN M; GRUMMEL A
    NON-AIDS PRIMARY CNS LYMPHOMA - THE 1ST EXAMPLE OF A DURABLE RESPONSEIN A PRIMARY BRAIN-TUMOR USING ENHANCED CHEMOTHERAPY DELIVERY WITHOUTCOGNITIVE LOSS AND WITHOUT RADIOTHERAPY
    Neurology
    
    E.A. Neuwelt et al., "NON-AIDS PRIMARY CNS LYMPHOMA - THE 1ST EXAMPLE OF A DURABLE RESPONSEIN A PRIMARY BRAIN-TUMOR USING ENHANCED CHEMOTHERAPY DELIVERY WITHOUTCOGNITIVE LOSS AND WITHOUT RADIOTHERAPY", Neurology, 45(4), 1995, pp. 400-400
20. DELOUGHERY TG; MCWILLIAMS JE; EVANS AJ; WISNER TW; TAYLOR LM; HENNER WD; PRESS R
    A GENETIC-DEFECT IN FOLATE METABOLISM WHICH LEADS TO HYPERHOMOCYST(E)INEMIA IS COMMON AND IS ASSOCIATED WITH VASCULAR-DISEASE
    Blood
    
    T.G. Deloughery et al., "A GENETIC-DEFECT IN FOLATE METABOLISM WHICH LEADS TO HYPERHOMOCYST(E)INEMIA IS COMMON AND IS ASSOCIATED WITH VASCULAR-DISEASE", Blood, 86(10), 1995, pp. 1494-1494
21. NEUWELT EA; WILIAMS PC; MICKEY BE; FRENKEL EP; HENNER WD
    THERAPEUTIC DILEMMA OF DISSEMINATED CNS GERMINOMA AND THE POTENTIAL OF INCREASED PLATINUM-BASED CHEMOTHERAPY DELIVERY WITH OSMOTIC BLOOD-BRAIN-BARRIER DISRUPTION
    Pediatric neurosurgery
    
    E.A. Neuwelt et al., "THERAPEUTIC DILEMMA OF DISSEMINATED CNS GERMINOMA AND THE POTENTIAL OF INCREASED PLATINUM-BASED CHEMOTHERAPY DELIVERY WITH OSMOTIC BLOOD-BRAIN-BARRIER DISRUPTION", Pediatric neurosurgery, 21(1), 1994, pp. 16-22
22. WINTERS TA; HENNER WD; RUSSELL PS; MCCULLOUGH A; JORGENSEN TJ
    REMOVAL OF 3'-PHOSPHOGLYCOLATE FROM DNA STRAND-BREAK DAMAGE IN AN OLIGONUCLEOTIDE SUBSTRATE BY RECOMBINANT HUMAN APURINIC APYRIMIDINIC ENDONUCLEASE-1/
    Nucleic acids research
    
    T.A. Winters et al., "REMOVAL OF 3'-PHOSPHOGLYCOLATE FROM DNA STRAND-BREAK DAMAGE IN AN OLIGONUCLEOTIDE SUBSTRATE BY RECOMBINANT HUMAN APURINIC APYRIMIDINIC ENDONUCLEASE-1/", Nucleic acids research, 22(10), 1994, pp. 1866-1873
23. CARRIER F; SMITH ML; BAE I; KILPATRICK KE; LANSING TJ; CHEN CY; ENGELSTEIN M; FRIEND SH; HENNER WD; GILMER TM; KASTAN MB; FORNACE AJ
    CHARACTERIZATION OF HUMAN GADD45, A P53-REGULATED PROTEIN
    The Journal of biological chemistry
    
    F. Carrier et al., "CHARACTERIZATION OF HUMAN GADD45, A P53-REGULATED PROTEIN", The Journal of biological chemistry, 269(51), 1994, pp. 32672-32677
24. COMSTOCK KE; WIDERSTEN M; HAO XY; HENNER WD; MANNERVIK B
    A COMPARISON OF THE ENZYMATIC AND PHYSICOCHEMICAL PROPERTIES OF HUMANGLUTATHIONE TRANSFERASE M4-4 AND 3 OTHER HUMAN MU-CLASS ENZYMES
    Archives of biochemistry and biophysics
    
    K.E. Comstock et al., "A COMPARISON OF THE ENZYMATIC AND PHYSICOCHEMICAL PROPERTIES OF HUMANGLUTATHIONE TRANSFERASE M4-4 AND 3 OTHER HUMAN MU-CLASS ENZYMES", Archives of biochemistry and biophysics, 311(2), 1994, pp. 487-495
25. ZUO J; FANG FD; DING L; HENNER WD; XIE DY
    GLUTATHIONE-S-TRANSFERASE ISOENZYMES AS MARKER IN PRENEOPLASIA OF RATCHEMICAL HEPATOCARCINOGENESIS
    Chinese Science Bulletin
    
    J. Zuo et al., "GLUTATHIONE-S-TRANSFERASE ISOENZYMES AS MARKER IN PRENEOPLASIA OF RATCHEMICAL HEPATOCARCINOGENESIS", Chinese Science Bulletin, 38(7), 1993, pp. 602-607
26. HENNER WD
    FANCONI-ANEMIA AMONG THE DNA-REPAIR DEFICIENCIES
    Experimental hematology
    
    W.D. Henner, "FANCONI-ANEMIA AMONG THE DNA-REPAIR DEFICIENCIES", Experimental hematology, 21(5), 1993, pp. 709-709
27. COMSTOCK KE; JOHNSON KJ; RIFENBERY D; HENNER WD
    ISOLATION AND ANALYSIS OF THE GENE AND CDNA FOR A HUMAN MU CLASS GLUTATHIONE-S-TRANSFERASE, GSTM4
    The Journal of biological chemistry
    
    K.E. Comstock et al., "ISOLATION AND ANALYSIS OF THE GENE AND CDNA FOR A HUMAN MU CLASS GLUTATHIONE-S-TRANSFERASE, GSTM4", The Journal of biological chemistry, 268(23), 1993, pp. 16958-16965